The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Transporters as a determinant of drug clearance and tissue distribution
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
The superfamily of organic anion transporting polypeptides
Hagenbuch, B., & Meier, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00633-8 · Cited by 861
Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797
A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.-P., & Kirchgessner, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37161 · Cited by 641
Clinical Pharmacokinetics of Atorvastatin
Lennern??s, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00005 · Cited by 623
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 597
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
The Gut as a Barrier to Drug Absorption: Combined Role of Cytochrome P450 3A and P-Glycoprotein
Zhang, Y., & Benet, L. Z. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140030-00002 · Cited by 518
Nishizato, Y. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00060-2 · Cited by 511
Cha, S. H., Sekine, T., Fukushima, J.-I., Kanai, Y., Kobayashi, Y., Goya, T., & Endou, H. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12589-8 · Cited by 508
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Self-citationKusuhara, H., Sekine, T., Utsunomiya-Tate, N., Tsuda, M., Kojima, R., Cha, S. H., Sugiyama, Y., Kanai, Y., & Endou, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13675 · Cited by 489
Self-citationCellular and molecular aspects of drug transport in the kidney
Inui, K.-I., Masuda, S., & Saito, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00251.x · Cited by 450
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068056 · Cited by 443
Self-citationInvolvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
Wang, D.-S., Jonker, J. W., Kato, Y., Kusuhara, H., Schinkel, A. H., & Sugiyama, Y. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034140 · Cited by 441
Self-citationNiemi, M., Schaeffeler, E., Lang, T., Fromm, M. F., Neuvonen, M., Kyrklund, C., Backman, J. T., Kerb, R., Schwab, M., Neuvonen, P. J., et al. (2004) · Pharmacogenetics · doi:10.1097/01.fpc.0000114750.08559.32 · Cited by 418
Kobayashi, D., Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051300 · Cited by 416
Shitara, Y., Hirano, M., Sato, H., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068536 · Cited by 407
Self-citationNeuvonen, P. J., Kantola, T., & Kivistö, K. T. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90165-5 · Cited by 406
Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport
Wright, S. H., & Dantzler, W. H. (2004) · Physiological Reviews · doi:10.1152/physrev.00040.2003 · Cited by 404
Carrier-Mediated Intestinal Transport of Drugs
Tsuji, A., & Tamai, I. (1996) · Pharmaceutical Research · doi:10.1023/a:1016086003070 · Cited by 392
Kameyama, Y., Yamashita, K., Kobayashi, K., Hosokawa, M., & Chiba, K. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000170913.73780.5f · Cited by 379
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
Vavricka, S. R., Van Montfoort, J., Ha, H. R., Meier, P. J., & Fattinger, K. (2002) · Hepatology · doi:10.1053/jhep.2002.34133 · Cited by 373
Transporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363
Meier, P. J., Eckhardt, U., Schroeder, A., Hagenbuch, B., & Stieger, B. (1997) · Hepatology · doi:10.1002/hep.510260641 · Cited by 362
NIEMI, M., BACKMAN, J., KAJOSAARI, L., LEATHART, J., NEUVONEN, M., DALY, A., EICHELBAUM, M., KIVISTO, K., & NEUVONEN, P. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.018 · Cited by 360
HO, E. S., LIN, D. C., MENDEL, D. B., & CIHLAR, T. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113383 · Cited by 356
Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human
Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060194 · Cited by 351
Cihlar, T., Lin, D. C., Pritchard, J. B., Fuller, M. D., Mendel, D. B., & Sweet, D. H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23084-4 · Cited by 345
Shitara, Y., Itoh, T., Sato, H., Li, A. P., & Sugiyama, Y. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041921 · Cited by 340
Self-citationFichtenbaum, C. J., Gerber, J. G., Rosenkranz, S. L., Segal, Y., Aberg, J. A., Blaschke, T., Alston, B., Fang, F., Kosel, B., & Aweeka, F. (2002) · AIDS · doi:10.1097/00002030-200203080-00008 · Cited by 338
EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS
Shitara, Y., Sato, H., & Sugiyama, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121444 · Cited by 336
Self-citationGemfibrozil greatly increases plasma concentrations of cerivastatin
Backman, J. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128469 · Cited by 336
SIMONSON, S. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.03.010 · Cited by 330
Tirona, R. G., Leake, B. F., Wolkoff, A. W., & Kim, R. B. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043026 · Cited by 324
The multispecific organic anion transporter (OAT) family
Sekine, T., Cha, S. H., & Endou, H. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000297 · Cited by 323
Lilja, J. J., Kivistö, K. T., & Neuvonen, P. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90130-8 · Cited by 312
Active secretion and enterocytic drug metabolism barriers to drug absorption
Wacher, V. J., Salphati, L., & Benet, L. Z. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00127-s · Cited by 308
Effect of itraconazole on the pharmacokinetics of atorvastatin*
Kantola, T., Kivistö, K. T., & Neuvonen, P. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90023-6 · Cited by 300
Han, H.-K., de Vrueh, R. L. A., Rhie, J. K., Covitz, K.-M. Y., Smith, P. L., Lee, C.-P., Oh, D.-M., Sadee, W., & Amidon1, G. L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011919319810 · Cited by 297
Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics
Mwinyi, J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.016 · Cited by 293
The effect of gemfibrozil on the pharmacokinetics of rosuvastatin
Schneck, D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.014 · Cited by 292
Hepatic Transport of Bile Salts
KULLAK-UBLICK, G. A., STIEGER, B., HAGENBUCH, B., & MEIER, P. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9426 · Cited by 291
Dresser, M. J., Leabman, M. K., & Giacomini, K. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<397::aid-jps1000>3.0.co;2-d · Cited by 290
Kantola, T., Kivistö, K. T., & Neuvonen, P. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90151-5 · Cited by 286
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Kobayashi, Y., Yamamoto, T., Cha, S. H., Sekine, T., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.918 · Cited by 276
Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid*
Kantola, T., Kivistö, K. T., & Neuvonen, P. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90034-0 · Cited by 276
Ganapathy, M. E., Brandsch, M., Prasad, P. D., Ganapathy, V., & Leibach, F. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25672 · Cited by 274
Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist
Dingemanse, J., & van Giersbergen, P. L. M. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443150-00003 · Cited by 272
Schuetz, E. G., Schinkel, A. H., Relling, M. V., & Schuetz, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4001 · Cited by 266
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Self-citationSelective Substrates for Non-Neuronal Monoamine Transporters
Gründemann, D., Liebich, G., Kiefer, N., Köster, S., & Schömig, E. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.1 · Cited by 245
Hepatic Secretion of Conjugated Drugs and Endogenous Substances
KEPPLER, D., & KÖNIG, J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9391 · Cited by 245
Wacher, V. J., Salphati, L., & Benet, L. Z. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00126-5 · Cited by 245
Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin
LILJA, J., KIVISTO, K., & NEUVONEN, P. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90048-6 · Cited by 241
Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid
Neuvonen, P. J., & Jalava, K.-M. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90167-8 · Cited by 238
Active efflux across the blood-brain barrier: Role of the solute carrier family
Kusuhara, H., & Sugiyama, Y. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.73 · Cited by 236
Self-citationSasaki, M., Suzuki, H., Ito, K., Abe, T., & Sugiyama, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109081200 · Cited by 228
Self-citationClinical Pharmacokinetics of Pravastatin: Mechanisms of Pharmacokinetic Events
Hatanaka, T. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039060-00002 · Cited by 224
Recent Advances in Carrier-mediated Hepatic Uptake and Biliary Excretion of Xenobiotics
Yamazaki, M., Suzuki, H., & Sugiyama, Y. (1996) · Pharmaceutical Research · doi:10.1023/a:1016077517241 · Cited by 221
Self-citationDrug Uptake Systems in Liver and Kidney
van Montfoort, J., Hagenbuch, B., Groothuis, G., Koepsell, H., Meier, P., & Meijer, D. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489460 · Cited by 221
Ohtsuki, S., Asaba, H., Takanaga, H., Deguchi, T., Hosoya, K., Otagiri, M., & Terasaki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01108.x · Cited by 219
Nakai, D., Nakagomi, R., Furuta, Y., Tokui, T., Abe, T., Ikeda, T., & Nishimura, K. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29609-9 · Cited by 217
Bidstrup, T. B., Bjørnsdottir, I., Sidelmann, U. G., Thomsen, M. S., & Hansen, K. T. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2003.01862.x · Cited by 209
Cyclosporine markedly raises the plasma concentrations of repaglinide
KAJOSAARI, L., NIEMI, M., NEUVONEN, M., LAITILA, J., NEUVONEN, P., & BACKMAN, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.07.005 · Cited by 207
Cui, Y., König, J., & Keppler, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12502-3 · Cited by 206
A Review of the Pharmacologic and Pharmacokinetic Aspects of Rosuvastatin
White, C. M. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127000204200902 · Cited by 199
Human Hepatobiliary Transport of Organic Anions Analyzed by Quadruple-Transfected Cells
Kopplow, K., Letschert, K., König, J., Walter, B., & Keppler, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014605 · Cited by 197
Involvement of Organic Cation Transporter 1 in the Lactic Acidosis Caused by Metformin
Wang, D.-S., Kusuhara, H., Kato, Y., Jonker, J. W., Schinkel, A. H., & Sugiyama, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.844 · Cited by 191
Self-citationMatsushima, S., Maeda, K., Kondo, C., Hirano, M., Sasaki, M., Suzuki, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085589 · Cited by 190
Self-citationShimizu, M., Fuse, K., Okudaira, K., Nishigaki, R., Maeda, K., Kusuhara, H., & Sugiyama, Y. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004622 · Cited by 183
Self-citationBile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin
Hirano, M., Maeda, K., Hayashi, H., Kusuhara, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084830 · Cited by 181
Self-citationTerada, T., & Inui, K.-I. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489153 · Cited by 177
Tahara, H., Kusuhara, H., Endou, H., Koepsell, H., Imaoka, T., Fuse, E., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088104 · Cited by 171
Self-citationEffect of () variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
CHUNG, J., CHO, J., YU, K., KIM, J., OH, D., JUNG, H., LIM, K., MOON, K., SHIN, S., & JANG, I. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.07.003 · Cited by 170
Huang, L., Wang, Y., & Grimm, S. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007534 · Cited by 169
MUCK, W., MAI, I., FRITSCHE, L., OCHMANN, K., ROHDE, G., UNGER, S., JOHNE, A., BAUER, S., BUDDE, K., & ROOTS, I. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70104-9 · Cited by 158
Yamazaki, M., Suzuki, H., Hanano, M., Tokui, T., Komai, T., & Sugiyama, Y. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.264.1.g36 · Cited by 152
Self-citationCattori, V., Hagenbuch, B., Hagenbuch, N., Stieger, B., Ha, R., Winterhalter, K. H., & Meier, P. J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01596-9 · Cited by 144
Hsyu, P., Schultz-Smith, M. D., Lillibridge, J. H., Lewis, R. H., & Kerr, B. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3445-3450.2001 · Cited by 144
Hasegawa, M., Kusuhara, H., Sugiyama, D., Ito, K., Ueda, S., Endou, H., & Sugiyama, Y. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.746 · Cited by 141
Self-citationLau, Y. Y., Okochi, H., Huang, Y. L., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093088 · Cited by 140
Yamazaki, M., Akiyama, S., Ni'inuma, K., Nishigaki, R., & Sugiyama, Y. (1997) · PubMed · doi:10.7270/q2cr5vmx · Cited by 140
Self-citationMazzu, A. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110537 · Cited by 136
Clinical Pharmacokinetics of Cerivastatin
ck, W. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00002 · Cited by 135
Niemi, M., Kivistö, K. T., Hofmann, U., Schwab, M. G., Eichelbaum, M. F., & Fromm, M. F. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02354.x · Cited by 135
Wada, S., Tsuda, M., Sekine, T., Ho, S., Kimura, M., Kanai, Y., & Endou, H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39144-x · Cited by 128
BindingDB (2013) · PubMed · doi:10.7270/q2h41sjq · Cited by 126
Absorption of Peptide and Peptidomimetic Drugs
Amidon, G. L., & Lee, H. J. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001541 · Cited by 124
Hagenbuch, B., Scharschmidt, B. F., & Meier, P. J. (1996) · Biochemical Journal · doi:10.1042/bj3160901 · Cited by 122
Interaction of human organic anion transporters with various cephalosporin antibiotics
Takeda, M., Babu, E., Narikawa, S., & Endou, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01306-7 · Cited by 121
Erythromycin Coadministration Increases Plasma Atorvastatin Concentrations
Siedlik, P. H., Olson, S. C., Yang, B., & Stern, R. H. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/009127009903900510 · Cited by 110
HEPATIC UPTAKE OF THE NOVEL ANTIFUNGAL AGENT CASPOFUNGIN
Sandhu, P., Lee, W., Xu, X., Leake, B. F., Yamazaki, M., Stone, J. A., Lin, J. H., Pearson, P. G., & Kim, R. B. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003244 · Cited by 109
Shitara, Y., Sugiyama, D., Kusuhara, H., Kato, Y., Abe, T., Meier, P. J., Itoh, T., & Sugiyama, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1014264614637 · Cited by 107
Self-citationEfflux transport systems for organic anions and cations at the blood?CSF barrier
Kusuhara, H., & Sugiyama, Y. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.007 · Cited by 106
Self-citationA Review of the Pharmacologic and Pharmacokinetic Aspects of Rosuvastatin
White, C. M. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401102876 · Cited by 100
Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors
Fujino, H., Saito, T., Tsunenari, Y., Kojima, J., & Sakaeda, T. (2004) · Xenobiotica · doi:10.1080/00498250400015319 · Cited by 98
Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin
Nezasa, K.-I., Higaki, K., Takeuchi, M., Nakano, M., & Koike, M. (2003) · Xenobiotica · doi:10.1080/0049825031000066259 · Cited by 98
Wenzel, U., Gebert, I., Weintraut, H., Weber, W. M., Clauss, W. G., & Daniel, H. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12941-8 · Cited by 97
Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A
Binet, I., Wallnöfer, A., Weber, C., Jones, R. D., & Thiel, G. T. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00838.x · Cited by 97
Sasaki, M., Suzuki, H., Aoki, J., Ito, K., Meier, P. J., & Sugiyama, Y. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05627-x · Cited by 96
Self-citationRecognition of β-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1cells
Terada, T., Saito, H., Mukai, M., & Inui, K. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.5.f706 · Cited by 96
Takeda, M., Noshiro, R., Onozato, M. L., Tojo, A., Hasannejad, H., Huang, X.-L., Narikawa, S., & Endou, H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.017 · Cited by 89
Ishizuka, H., Konno, K., Naganuma, H., Sasahara, K., Kawahara, Y., Niinuma, K., Suzuki, H., & Sugiyama, Y. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36523-1 · Cited by 85
Self-citationPang, K. S., & Gillette, J. R. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31406-0 · Cited by 85
ROGERS, J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.a101208 · Cited by 84
Treiber, A., Schneiter, R., Delahaye, S., & Clozel, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061614 · Cited by 83
Molecular Cloning and Functional Analyses of OAT1 and OAT3 from Cynomolgus Monkey Kidney
Tahara, H., Shono, M., Kusuhara, H., Kinoshita, H., Fuse, E., Takadate, A., Otagiri, M., & Sugiyama, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2503-0 · Cited by 82
Self-citationTokui, T., Nakai, D., Nakagomi, R., Yawo, H., Abe, T., & Sugiyama, Y. (1999) · Pharmaceutical Research · doi:10.1023/a:1018838405987 · Cited by 79
Self-citationKouzuki, H., Suzuki, H., Ito, K., Ohashi, R., & Sugiyama, Y. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37686-4 · Cited by 78
Self-citationThe Inhibitory Effect of Probenecid on Renal Excretion of Famotidine in Young, Healthy Volunteers
Inotsume, N., Nishimura, M., Nakano, M., et al. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03438.x · Cited by 78
Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitors
Sirtori, C. R. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90031-8 · Cited by 77
Sasaki, K., Makita, N., Sunami, A., Sakurada, H., Shirai, N., Yokoi, H., Kimura, A., Tohse, N., Hiraoka, M., & Kitabatake, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.330 · Cited by 74
Pang, K. S., Wang, P. J., Chung, A. Y., & Wolkoff, A. W. (1998) · Hepatology · doi:10.1002/hep.510280524 · Cited by 69
Yamazaki, M., Akiyama, S., Nishigaki, R., & Sugiyama, Y. (1996) · Pharmaceutical Research · doi:10.1023/a:1016044032571 · Cited by 65
Self-citationPhysiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2
Inui, K., Terada, T., Masuda, S., & Saito, H. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.suppl_6.11 · Cited by 65
Mita, S., Suzuki, H., Akita, H., Stieger, B., Meier, P. J., Hofmann, A. F., & Sugiyama, Y. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2003 · Cited by 63
Self-citationAmsden, G. W., Kuye, O., & Wei, G. C. G. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011373 · Cited by 60
Jung, K. Y., Takeda, M., Shimoda, M., Narikawa, S., Tojo, A., Kim, D. K., Chairoungdua, A., Choi, B. K., Kusuhara, H., Sugiyama, Y., et al. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01500-x · Cited by 59
Self-citationPeptide transport in intestinal and renal brush border membrane vesicles
Ganapathy, V., & Leibach, F. H. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90287-9 · Cited by 58
Ueda, K., Kato, Y., Komatsu, K., & Sugiyama, Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29630-0 · Cited by 58
Self-citationBile acid and xenobiotic transporters in liver
Stieger, B., & Meier, P. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80059-8 · Cited by 56
Tahara, H., Kusuhara, H., Chida, M., Fuse, E., & Sugiyama, Y. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094052 · Cited by 54
Self-citationInteractions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver
Ismair, M. G. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00154-2 · Cited by 51
Kouzuki, H., Suzuki, H., Ito, K., Ohashi, R., & Sugiyama, Y. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37999-6 · Cited by 50
Self-citationYamazaki, M., Tokui, T., Ishigami, M., & Sugiyama, Y. (1996) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199612)17:9<775::aid-bdd990>3.0.co;2-s · Cited by 47
Self-citationTransport of cimetidine by flounder and human renal organic anion transporter 1
Burckhardt, B. C., Brai, S., Wallis, S., Krick, W., Wolff, N. A., & Burckhardt, G. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00290.2002 · Cited by 45
Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat hepatocytes.
Ishigami, M., Tokui, T., KOMAI, T., Tsukahara, K., Yamazaki, M., & Sugiyama, Y. (1995) · Pharmaceutical Research · doi:10.1023/a:1016226024587 · Cited by 43
Self-citationCarrier-Mediated Hepatic Uptake of Quinolone Antibiotics in the Rat
Sasabe, H., Terasaki, T., Tsuji, A., & Sugiyama, Y. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36787-4 · Cited by 42
Self-citationHan, H.-K., Rhie, J. K., Oh, D.-M., Saito, G., Hsu, C.-P., Stewart, B. H., & Amidon, G. L. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980132e · Cited by 42
Abu-Zahra, T. N., Wolkoff, A. W., Kim, R. B., & Pang, K. S. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15350-0 · Cited by 37
Hirono, S., Nakagome, I., Imai, R., Maeda, K., Kusuhara, H., & Sugiyama, Y. (2005) · Pharmaceutical Research · doi:10.1007/s01869-005-1869-8 · Cited by 37
Self-citationPetzinger, E., & Fückel, D. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90627-g · Cited by 27
Cited by
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Self-citationWhy 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationPolymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
From carbohydrate leads to glycomimetic drugs
Ernst, B., & Magnani, J. L. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2852 · Cited by 820
Metadata
- Authors
- Shitara, Y., Horie, T., & Sugiyama, Y.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 27
- Issue
- 5
- Pages
- 425-446
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2064413682
- Cited by
- 496
- References
- 134
- FWCI
- 19.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.